Probiotics/prebiotics/synbiotics and human neuropsychiatric outcomes: an umbrella review.
Sign Up to like & getrecommendations! Published in 2024 at "Beneficial microbes"
DOI: 10.1163/18762891-bja00035
Abstract: The neuropsychiatric effects of probiotics, prebiotics, and synbiotics have been gaining attention since the rise of microbial-gut-brain axis research. Nevertheless, some of the findings are inconsistent, and few studies have analysed the similarities and differences… read more here.
Keywords: neuropsychiatric effects; probiotics prebiotics; prebiotics synbiotics; umbrella review ... See more keywords
Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review
Sign Up to like & getrecommendations! Published in 2022 at "Biomolecules"
DOI: 10.3390/biom12101462
Abstract: Cannabidiol (CBD) is a non-intoxicating cannabinoid compound with diverse molecular targets and potential therapeutic effects, including effects relevant to the treatment of psychiatric disorders. In this scoping review, we sought to determine the extent to… read more here.
Keywords: neuropsychiatric effects; scoping review; sex; effects pharmacokinetics ... See more keywords
Efavirenz and neuropsychiatric effects
Sign Up to like & getrecommendations! Published in 2017 at "Southern African Journal of HIV Medicine"
DOI: 10.4102/sajhivmed.v18i1.741
Abstract: Currently efavirenz (EFV) is widely prescribed as part of antiretroviral therapy (ART) in South Africa and it is most frequently prescribed in fixed-dose combination (FDC) at a dose of 600 mg. Efavirenz has been linked… read more here.
Keywords: neuropsychiatric effects; toxicity; efv toxicity; adverse drug ... See more keywords